Cargando…

Preliminary Evidence of Efficacy and Target Engagement of Pramipexole in Anhedonic Depression

OBJECTIVE: To investigate feasibility and target engagement of high‐dose, add‐on pramipexole treatment in anhedonic depression. METHOD: In this open‐label pilot study, we included 12 patients with unipolar or bipolar, moderate‐to‐severe depression and with significant anhedonia symptoms. All patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ventorp, Filip, Lindahl, Jesper, van Westen, Danielle, Jensen, Jimmy, Björkstrand, Johannes, Lindqvist, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534553/ https://www.ncbi.nlm.nih.gov/pubmed/36225720 http://dx.doi.org/10.1176/appi.prcp.20210042

Ejemplares similares

Add-on pramipexole for anhedonic depression: study protocol for a randomised controlled trial and open-label follow-up in Lund, Sweden
por: Lindahl, Jesper, et al.
Publicado: (2023)

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT
por: Dormegny-Jeanjean, Ludovic Christophe, et al.
Publicado: (2023)

Efficacy of eicosapentaenoic acid in inflammatory depression: study protocol for a match-mismatch trial
por: Suneson, Klara, et al.
Publicado: (2022)

A reduction in positive self-judgment bias is uniquely related to the anhedonic symptoms of depression
por: Dunn, Barnaby D., et al.
Publicado: (2009)

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
por: Lally, N, et al.
Publicado: (2014)

The association between type 2 diabetes and anhedonic subtype of major depression in hypertensive individuals
por: Willame, Hadrien, et al.
Publicado: (2022)

25(OH)D levels are decreased in patients with difficult-to-treat depression
por: Grudet, C., et al.
Publicado: (2022)

Beneficial effect of pramipexole for motor function and depression in Parkinson’s disease
por: Kano, Osamu, et al.
Publicado: (2008)

Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms
por: Heitmann, Henrik, et al.
Publicado: (2020)

Anhedonic depression, history of depression, and anxiety as gender-specific risk factors of myocardial infarction in healthy men and women: The HUNT study
por: Langvik, Eva, et al.
Publicado: (2014)

The Sweet Drive Test: refining phenotypic characterization of anhedonic behavior in rodents
por: Mateus-Pinheiro, António, et al.
Publicado: (2014)

Pramipexole use and the risk of pneumonia
por: Ernst, Pierre, et al.
Publicado: (2012)

Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion
por: Castro-Hernández, Javier, et al.
Publicado: (2017)

Pramipexole: new use for an old drug – the potential use of pramipexole in the treatment of restless legs syndrome
por: Benbir, Gulcin, et al.
Publicado: (2006)

The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial
por: Hori, Hiroaki, et al.
Publicado: (2012)

Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression
por: Rossetti, Andrea C., et al.
Publicado: (2022)

Modeling socially anhedonic syndromes: genetic and pharmacological manipulation of opioid neurotransmission in mice
por: Cinque, C, et al.
Publicado: (2012)

A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
por: Pulcu, Erdem, et al.
Publicado: (2021)

Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint Stress
por: Kim, Hye Ji J., et al.
Publicado: (2023)

Pramipexole in the Treatment of Refractory Depression in a Patient with Rapid Cycling Bipolar Disorder
por: Hegde, Aditya, et al.
Publicado: (2015)

Burning mouth syndrome responsive to pramipexol
por: Stuginski-Barbosa, J., et al.
Publicado: (2008)

Automatic behavior and communication due to pramipexole
por: Walker, Ruth H.
Publicado: (2016)

Sucrose Preference Test as a Measure of Anhedonic Behavior in a Chronic Unpredictable Mild Stress Model of Depression: Outstanding Issues
por: Markov, Dmitrii D.
Publicado: (2022)

Preliminary clinical and cost effectiveness of augmented depression therapy versus cognitive behavioural therapy for the treatment of anhedonic depression (ADepT): a single-centre, open-label, parallel-group, pilot, randomised, controlled trial
por: Dunn, Barnaby D., et al.
Publicado: (2023)

Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
por: Suneson, Klara, et al.
Publicado: (2021)

Update on the use of pramipexole in the treatment of Parkinson’s disease
por: Constantinescu, Radu
Publicado: (2008)

Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole
por: Ferrari-Toninelli, Giulia, et al.
Publicado: (2010)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
por: Piedad, John C. P., et al.
Publicado: (2012)

Gold nanoclusters as prospective carriers and detectors of pramipexole
por: Si, Nguyen Thanh, et al.
Publicado: (2021)

A proof of principle for using adaptive testing in routine Outcome Monitoring: the efficiency of the Mood and Anxiety Symptoms Questionnaire -Anhedonic Depression CAT
por: Smits, Niels, et al.
Publicado: (2012)

Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes
por: Winlow, William
Publicado: (2005)

Alpha-amylase reactivity and recovery patterns in anhedonic young adults performing a tandem skydive
por: Vrijen, Charlotte, et al.
Publicado: (2018)

Anhedonic Type Behavior and Anxiety Profile of Wistar-UIS Rats Subjected to Chronic Social Isolation
por: Acero-Castillo, María Camila, et al.
Publicado: (2021)

Comparison of pramipexole and citalopram in the treatment of depression in Parkinson's disease: A randomized parallel-group trial
por: Ziaei, Ehsan, et al.
Publicado: (2022)

The use of pramipexole in drug-induced parkinsonism: A case study on a patient with bipolar depression
por: Bueno Sanya, L., et al.
Publicado: (2022)

Novel polygenic risk score as a translational tool linking depression-related changes in the corticolimbic transcriptome with neural face processing and anhedonic symptoms
por: Mareckova, Klara, et al.
Publicado: (2020)

Restless legs syndrome: differential diagnosis and management with pramipexole
por: Brindani, Francesca, et al.
Publicado: (2009)

Pramipexole effects on startle gating in rats and normal men
por: Swerdlow, Neal R., et al.
Publicado: (2009)

Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129
por: Chau, Kai-Yin, et al.
Publicado: (2013)

Pramipexole and its Extended Release Formulation for Parkinson’s Disease
por: Fishman, Paul S.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4ik4ghhga13f70o2hrsku2uv3e